Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?
暂无分享,去创建一个
M. Hoogendoorn | A. Schols | M. R. Rutten-van Mölken | M. R. Mölken | C. R. van Wetering | C. R. V. Wetering
[1] M. Hoogendoorn,et al. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial , 2009, Thorax.
[2] M. Hoogendoorn,et al. Cost-Effectiveness of a 24 Month INTERdisciplinary COMmunity-Based COPD Management Program (INTERCOM) in Patients with Less Advanced Airflow Obstruction. , 2009, ATS 2009.
[3] J. Vles,et al. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost‐effectiveness analysis , 2008, Developmental medicine and child neurology.
[4] Peter C Levendag,et al. Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery. , 2005, Brachytherapy.
[5] M. Hoogendoorn,et al. P207 Outstanding abstract EFFECTIVENESS OF A 24 MONTH INTERDISCIPLINARY COMMUNITY-BASED COPD LIFESTYLE PROGRAM (INTERCOM) IN PATIENTS WITH MODERATE COPD , 2008 .
[6] Y. Lacasse,et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. , 2007, Europa medicophysica.
[7] Thierry Troosters,et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.
[8] A. van Straten,et al. Cost-utility of brief psychological treatment for depression and anxiety , 2006, British Journal of Psychiatry.
[9] R. Willke,et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] P. Jones. St. George's Respiratory Questionnaire: MCID , 2005, COPD.
[11] M. Polkey,et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study , 2004, BMJ : British Medical Journal.
[12] Andrew Briggs,et al. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. , 2004, Health economics.
[13] Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. , 2004, Journal of cardiopulmonary rehabilitation.
[14] D. Sin,et al. Economic Evaluation of a Community-Based Pulmonary Rehabilitation Program for Chronic Obstructive Pulmonary Disease , 2004, Lung.
[15] J. van der Palen,et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[16] E. Wouters,et al. Chronic obstructive pulmonary disease • 5: Systemic effects of COPD , 2002, Thorax.
[17] M. Burr,et al. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme , 2001, Thorax.
[18] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[19] M. Decramer,et al. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.
[20] G H Guyatt,et al. Long-term effects of outpatient rehabilitation of COPD: A randomized trial. , 2000, Chest.
[21] P. Bakke,et al. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? , 1999, American journal of respiratory and critical care medicine.
[22] N. Ambrosino,et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.
[23] M. Morgan,et al. A short outpatient pulmonary rehabilitation programme: immediate and longer-term effects on exercise performance and quality of life. , 1998, Respiratory medicine.
[24] H. Folgering,et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. , 1998, The European respiratory journal.
[25] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[26] G. Guyatt,et al. Economic analysis of respiratory rehabilitation. , 1997, Chest.
[27] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[28] J. Bach,et al. The cost/benefits of outpatient-based pulmonary rehabilitation. , 1997, Archives of physical medicine and rehabilitation.
[29] R. Brooks. EuroQol: the current state of play. , 1996, Health policy.
[30] M A Koopmanschap,et al. The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.
[31] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[32] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[33] P. Jones,et al. The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.
[34] D B Rubin,et al. Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.
[35] D. Rubin,et al. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .